Abstract Cognitive decline is a hallmark of Alzheimer’s disease (AD). Cannabidiol (CBD), a non-intoxicating phytocannabinoid with immunomodulatory properties, shows promise…
Abstract Depression and obesity are comorbid conditions linked through shared neuroinflammatory and immune mechanisms. This study examined the effects of…
Abstract Evidence indicates a bidirectional link between depressive symptoms and neuroinflammation. This study evaluated chronic cannabidiol (CBD) treatment effects in…
Abstract Post-traumatic stress disorder (PTSD) is a debilitating neuropsychiatric condition closely linked to neuroinflammation, with a higher prevalence in women.…
Abstract Aging is associated with changes in cognitive and emotional function. Cannabidiol (CBD) has been reported to attenuate stress and…
Abstract Cannabidiol (CBD) is a potential antidepressant agent. We examined the association between the antidepressant effects of CBD and alterations…
Abstract Depression is characterized by continuous low mood and loss of interest or pleasure in enjoyable activities. First-line medications for…
Abstract There have been growing concerns about the protracted effects of cannabis use in adolescents on emotion and cognition outcomes,…
Abstract Early life stress (ES) significantly increases predisposition to psychopathologies. Cannabinoids may cause cognitive deficits and exacerbate the effects of…
Abstract The use of cannabis can impair cognitive function, especially short-term memory. A controversial question is whether long-term cannabis use…